NEW YORK, Aug. 18, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Gene Therapy Market Analysis
http://www.reportlinker.com/p0324817/Global-Gene-Therapy-Market-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy
Gene therapy has come a long way during the past few years to become one of the most sought after methods to develop a disease treatment. In spite of only one therapy reaching the markets, the future seems to hold significant potential in terms of developing such approaches. Gene therapy advancements have allowed researchers to work with information regarding pathogenesis of diseases. The discipline heralds a significant potential for the biotechnology industry over the long term, as the approach moves from research labs to clinical trials.
According to our new research report, "Global Gene Therapy Market Analysis", the global gene therapy market is anticipated to grow stupendously in the coming years. The growth will be largely driven by the increasing interest of biopharma companies in the segment. The companies will not only look to develop the therapies for various diseases through in-house research, but also develop the ones acquired from other sources into full-fledged commercial forms. The industry is hailing gene therapy as the next frontier of medicine for its disease-specific approach which hits the target cause of the problem with utmost efficiency. As a result of this, the therapies currently in the development stage are able to clear the hurdles of safety and efficacy and are well on their way to being approved by the regulatory authorities.
Through in-depth and prudent analysis of the developments taking place at the global level, we have observed that the market is presently dominated by Oncology, Infectious diseases, and genetic disorder applications. However, therapeutic applications of gene therapy are extending to new therapy areas such as acquired diseases, especially the immunodeficiency syndromes. In addition, smaller companies are likely to become more visible in future as their products move closer to regulatory approvals.
Further, the US, Europe, Canada, China, and Japan are the major geographical markets exhibiting healthy growth rates. Our study indicates that the highest growth rate in the developing countries' gene therapy market is likely to be observed for the treatment of cancer, followed by infectious diseases like AIDS, etc.
The report provides extensive information and rational analysis of the global gene therapy market. Our team of researchers has thoroughly examined current market trends, industrial developments, and competitive landscapes to enable clients understand the market structure and its progress in the coming years. The report also gives an insight into the segment-wise market trends prevailing at the regional level to provide an overview of developments taking place in these segments across the world.
1. Analyst View
2. Research Methodology
3. Gene Therapy - An Introduction
4. Industry Trends
4.1 Gene Silencing: Eradicating the Root Cause
4.2 Advanced Therapies Combining Gene Therapy and Stem Cell Technology
4.3 Immunodeficiency Syndromes: The Focus of Gene Therapy
4.4 Expanded Use of Viral Vectors
4.5 Nanotechnology: Empowering Gene Therapy
5. Industry Overview
5.1 Market Size and Growth
5.2 By Application
5.2.1 Oncology
5.2.2 Infectious Diseases
5.2.3 Genetic Disorders
5.2.4 Acquired Diseases
5.3 Key Geographical Markets
5.3.1 US
5.3.2 Europe
5.3.3 Australia
5.3.4 Canada
5.3.5 Israel
5.3.6 Japan
5.3.7 China
5.3.8 India
5.4 Major Drugs
5.4.1 Gendicine
5.4.2 Oncorine
5.4.3 Cerepro
5.4.4 Glybera
6. Research & Development
6.1 By Stages
6.1.1 Phase I & II
6.1.2 Phase III
6.1.3 Phase IV
6.2 By Geography
7. Regulatory Environment
8. Key Players Analysis
8.1 Pfizer
8.2 GlaxoSmithKline
8.3 Genentech
8.4 Astrazeneca
8.5 Merck KGaA
8.6 ImClone LLC
8.7 Ark Therapeutics
8.8 Celgene Corporation
8.9 Shenzhen Si Biono Genetech Co. Ltd
8.10 Takeda Pharmaceuticals
List of Figures:
Figure 3-1: Schematic Diagram of Gene Therapy Technique
Figure 5-1: Global - Gene Therapy Market (Million US$), 2006 & 2011
List of Tables:
Table 6-1: Gene Therapy Industry Studies (2011)
Table 6-2: Gene Therapy Industry Open Studies in Phase III
Table 6-3: Gene Therapy Industry Open Studies in Phase IV
Table 6-4: Open Gene Therapy Industry Trials by Country (2011)
Table 8-1: Global - Major Gene Therapy Companies
To order this report:
Biological Therapy Industry: Global Gene Therapy Market Analysis
Biological Therapy Business News
Check our Company Profile, SWOT and Revenue Analysis!
Contact
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article